Bulk Manufacturer of Controlled Substances Registration, 60897 [2018-25875]

Download as PDF 60897 Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices Controlled substance Drug code Schedule Remifentanil ............................................................................................................................................................. 9739 II The company plans to import the above listed controlled substance for research purposes. DEPARTMENT OF JUSTICE Drug Enforcement Administration Administration (DEA) as bulk a manufacturer of various classes of schedule I and II controlled substances. Dated: November 16, 2018. John J. Martin, Assistant Administrator. [Docket No. DEA–392] SUPPLEMENTARY INFORMATION: Bulk Manufacturer of Controlled Substances Registration [FR Doc. 2018–25873 Filed 11–26–18; 8:45 am] ACTION: BILLING CODE 4410–09–P Notice of registration. The registrant listed below has applied for and been granted registration by the Drug Enforcement SUMMARY: The company listed below applied to be registered as bulk manufacturer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted for this notice. Company FR Docket Rhodes Technologies ............................................................. 83 FR 40567 .......................................................................... The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of this registrant to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed company. Dated: November 16, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–25875 Filed 11–26–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Cambridge Isotope Laboratories ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 27, 2018. Such persons may also file a written request for a hearing on the application on or before December 27, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette DATES: Published Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on August 30, 2018, Cambridge Isotope Laboratories, 50 Frontage Road, Andover, Massachusetts 01810 applied to be registered as an importer of the following basic classes of controlled substances: amozie on DSK3GDR082PROD with NOTICES1 Controlled substance Drug code Tetrahydrocannabinols ............................................................................................................................................ Gamma Hydroxybutyric Acid ................................................................................................................................... Morphine .................................................................................................................................................................. VerDate Sep<11>2014 17:45 Nov 26, 2018 Jkt 247001 PO 00000 Frm 00077 Fmt 4703 August 15, 2018. Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1 7370 2010 9300 Schedule I I II

Agencies

[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)]
[Notices]
[Page 60897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25875]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrant listed below has applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as bulk a 
manufacturer of various classes of schedule I and II controlled 
substances.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as bulk manufacturer of various basic classes of controlled 
substances. Information on the previously published notice is listed in 
the table below. No comments or objections were submitted for this 
notice.

------------------------------------------------------------------------
           Company                FR Docket             Published
------------------------------------------------------------------------
Rhodes Technologies..........  83 FR 40567....  August 15, 2018.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of this registrant to manufacture the 
applicable basic classes of controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed company.

    Dated: November 16, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-25875 Filed 11-26-18; 8:45 am]
 BILLING CODE 4410-09-P